NN

Nrup Naimishkumar Kansara

Active Director Director DIN 11239079
DIN 11239079 First appointment Aug 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value •••• Premium profile

About Nrup Naimishkumar Kansara

Data last updated:

Nrup Naimishkumar Kansara is a Director at Airmed Pathology Limited (since 2025). The company operates in Healthcare. Airmed Pathology Limited reported revenue of ₹12.40 Cr (FY 2025).

DIN 11239079
Primary Designation Director
Industry Healthcare
First Appointment 12 Aug 2025
Oldest Company Age 10 yrs
Largest company Airmed Pathology Limited · ₹12.40 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Airmed Pathology Limited U74999GJ2016PLC093344
Director12 Aug 20252016₹12.40 Cr (FY 2025)Active

Board colleagues of Nrup Naimishkumar Kansara

NameDINCompanyDesignation
Amit Omprakash Gupta02301199Airmed Pathology LimitedDirector
Aradhana Gupta02368925Airmed Pathology LimitedDirector

Directorship timeline

Open interactive timeline →
Airmed Pathology Limited
Premium access

Shareholding and investment profile for Nrup Naimishkumar Kansara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nrup Naimishkumar Kansara

Nrup Naimishkumar Kansara currently holds 1 directorship: Airmed Pathology Limited (Director, since 12 Aug 2025, revenue ₹12.40 Cr (FY 2025)).

Nrup Naimishkumar Kansara was first appointed on 12 Aug 2025 as Director at Airmed Pathology Limited.

The current boards of Nrup Naimishkumar Kansara's companies include Amit Omprakash Gupta (Airmed Pathology Limited), Aradhana Gupta (Airmed Pathology Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available